Aquestive Therapeutics, Inc. (AQST)

CIK 1398733 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aquestive Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 202640001214659-26-011596
Sep 10, 202640001214659-26-011541
Sep 9, 20261440001950047-26-009243
Sep 9, 202640001214659-26-011539
Sep 8, 202640001214659-26-011475
Aug 18, 202640001214659-26-010516
Aug 17, 20261440001950047-26-008250
Aug 17, 202640001214659-26-010474
Aug 11, 202610-Q0001398733-26-000042
Aug 11, 20268-K0001398733-26-000041
Aug 10, 20268-K0001398733-26-000035
Jul 27, 2026SCHEDULE 13G/A0002012383-26-002183
Jul 17, 202640001214659-26-008663
Jul 15, 20261440001950047-26-007131
Jul 9, 2026424B30001140361-26-028114
Jul 8, 2026EFFECT9999999995-26-002228
Jun 26, 2026S-30001140361-26-026568
Jun 24, 202640001214659-26-007677
Jun 23, 20261440001950047-26-006421
Jun 16, 202640001214659-26-007511
Jun 15, 20261440001950047-26-006103
Jun 12, 202640001214659-26-007397
Jun 12, 202640001214659-26-007396
Jun 12, 202640001214659-26-007395
Jun 12, 202640001214659-26-007399